Association of I405V Polymorphism of Colesteryl Ester Transfer Protein Gene with Coronary Artery Disease in Men with Type 2 Diabetes

Overview

Journal ARYA Atheroscler

Date 2016 Jul 19

PMID 27429626

Citations 1

Authors

Fatameh Karimpour

Ghorban Mohammadzadeh

Alireza Kheirollah

Mohammad Ali Ghaffari

Azadeh Saki

Affiliations

Soon will be listed here.

Abstract

Background: Colesteryl ester transfer protein (CETP) plays a key role in the metabolism of lipoproteins; therefore, polymorphisms of its gene can affect susceptibility to coronary artery disease (CAD) in diabetes mellitus. The aim of the present study was to investigate association between I405V polymorphism of CETP gene and risk of CAD in patients with type 2 diabetes mellitus.

Methods: The current case-control study was conducted on 143 patients with type 2 diabetes and angiographically diagnosed CAD and 150 patients with type 2 diabetes and without CAD. Genotyping was performed through polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The presence of CAD was defined as higher than 50% reduction in coronary artery diameter.

Results: The genotype frequencies of I405V polymorphism were II (27.3% vs. 23.2%), IV (61.5% vs. 67.5%), and VV (11.2% vs. 9.3%) in diabetic with CAD compared to diabetic without CAD (χ2 = 1.164) (P = 0.55). The I and V alleles were found at frequencies of 63.6% and 61.6% in the diabetic with CAD group and 36.4% and 38.4% in the diabetic without CAD group (χ2 = 0.263) (P = 0.60). No significant difference was observed between two groups in terms of genotype and allele frequency. Moreover, no significant association was observed between II, IV, and VV genotypes and lipid profiles in both groups. However, a significant difference was observed between genotype distributions of I405V polymorphism in men according to the severity of CAD.

Conclusion: It is speculated that I405V polymorphism may be associated with the severity of coronary artery stenosis only in men with type 2 diabetes mellitus.

Citing Articles

Cholesteryl Ester Transfer Protein (CETP) Variations in Relation to Lipid Profiles and Cardiovascular Diseases: An Update.

Dabravolski S, Orekhov N, Melnichenko A, Sukhorukov V, Popov M, Orekhov A Curr Pharm Des. 2024; 30(10):742-756.

PMID: 38425105 DOI: 10.2174/0113816128284695240219093612.

References

Isaacs A, Sayed-Tabatabaei F, Hofman A, Oostra B, Klungel O, Maitland-Vander Zee A . The cholesteryl ester transfer protein I405V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study. Eur J Cardiovasc Prev Rehabil. 2007; 14(3):419-21. DOI: 10.1097/HJR.0b013e32801101aa. View

Kolovou G, Vasiliadis I, Kolovou V, Karakosta A, Mavrogeni S, Papadopoulou E . The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease. Lipids Health Dis. 2011; 10:156. PMC: 3175181. DOI: 10.1186/1476-511X-10-156. View

Akbarzadeh M, Hassanzadeh T, Saidijam M, Esmaeili R, Borzouei S, Hajilooi M . Cholesteryl ester transfer protein (CETP) -629C/A polymorphism and it's effects on the serum lipid levels in metabolic syndrome patients. Mol Biol Rep. 2012; 39(10):9529-34. DOI: 10.1007/s11033-012-1817-3. View

Dogru-Abbasoglu S, Parildar-Karpuzoglu H, Depboylu B, Cine N, Uysal M, Aykac-Toker G . I405V and TaqIB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipoprotein levels in a Turkish population. Cell Biochem Funct. 2009; 27(2):76-80. DOI: 10.1002/cbf.1536. View

Samani K, Noori M, Rohbani Nobar M, Hashemzadeh Chaleshtori M, Farrokhi E, Darabi Amin M . I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease. Iran Biomed J. 2009; 13(2):103-8. View

Lloyd D, Lira M, Wood L, Durham L, Freeman T, Preston G . Cholesteryl ester transfer protein variants have differential stability but uniform inhibition by torcetrapib. J Biol Chem. 2005; 280(15):14918-22. DOI: 10.1074/jbc.M500523200. View

Plengpanich W, Siriwong S, Khovidhunkit W . Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia. Metabolism. 2009; 58(8):1178-84. DOI: 10.1016/j.metabol.2009.03.020. View

Borggreve S, Hillege H, Wolffenbuttel B, de Jong P, Zuurman M, van der Steege G . An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab. 2006; 91(9):3382-8. DOI: 10.1210/jc.2005-2322. View

Spielmann N, Leon A, Rao D, Rice T, Skinner J, Bouchard C . CETP genotypes and HDL-cholesterol phenotypes in the HERITAGE Family Study. Physiol Genomics. 2007; 31(1):25-31. DOI: 10.1152/physiolgenomics.00281.2006. View

10.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 Suppl 1:S62-9. PMC: 2797383. DOI: 10.2337/dc10-S062. View

11.

Barter P, Nicholls S, Rye K, Anantharamaiah G, Navab M, Fogelman A . Antiinflammatory properties of HDL. Circ Res. 2004; 95(8):764-72. DOI: 10.1161/01.RES.0000146094.59640.13. View

12.

Bruce C, Chouinard Jr R, Tall A . Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr. 1998; 18:297-330. DOI: 10.1146/annurev.nutr.18.1.297. View

13.

Kolovou G, Mihas C, Anagnostopoulou K, Kolovou V, Giannakopoulou V, Kostakou P . Cholesteryl ester transfer protein gene and effectiveness of lipid lowering of atorvastatin. Open Cardiovasc Med J. 2011; 4:297-301. PMC: 3111735. DOI: 10.2174/1874192401004010297. View

14.

Lewis G, Rader D . New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005; 96(12):1221-32. DOI: 10.1161/01.RES.0000170946.56981.5c. View

15.

Okumura K, Matsui H, Kamiya H, Saburi Y, Hayashi K, Hayakawa T . Differential effect of two common polymorphisms in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. Atherosclerosis. 2002; 161(2):425-31. DOI: 10.1016/s0021-9150(01)00653-0. View

16.

Khosravi A, Akhavan Tabib A, Golshadi I, Siadat Z, Bahonar A, Zarfeshani S . The Relationship between Weight and CVD Risk Factors in a Sample Population from Central Iran (Based on IHHP). ARYA Atheroscler. 2012; 8(2):82-9. PMC: 3463990. View

17.

Ghaffari M, Askari Sede S, Rashtchizadeh N, Mohammadzadeh G, Majidi S . Association of CRP gene polymorphism with CRP levels and Coronary Artery Disease in Type 2 Diabetes in Ahvaz, southwest of Iran. Bioimpacts. 2014; 4(3):133-9. PMC: 4204038. DOI: 10.15171/bi.2014.006. View

18.

Thompson J, Durham L, Lira M, Shear C, Milos P . CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease. Atherosclerosis. 2005; 181(1):45-53. DOI: 10.1016/j.atherosclerosis.2005.01.015. View

19.

Padmaja N, Kumar M, Soya S, Adithan C . Common variants of Cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population. Clin Chim Acta. 2006; 375(1-2):140-6. DOI: 10.1016/j.cca.2006.06.031. View

20.

Boekholdt S, Thompson J . Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res. 2003; 44(6):1080-93. DOI: 10.1194/jlr.R200018-JLR200. View